|
DDX17 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.93259996894568E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.20800003333699E-09 |
| Normal-vs-Stage2 |
6.351900E-04 |
| Normal-vs-Stage3 |
1.058160E-03 |
| Normal-vs-Stage4 |
7.496300E-03 |
| Stage1-vs-Stage2 |
6.850800E-01 |
| Stage1-vs-Stage3 |
1.078170E-01 |
| Stage1-vs-Stage4 |
9.040300E-02 |
| Stage2-vs-Stage3 |
1.664750E-01 |
| Stage2-vs-Stage4 |
1.363790E-01 |
| Stage3-vs-Stage4 |
8.056000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.6601999986452E-08 |
| Normal-vs-AfricanAmerican |
3.89680000000281E-05 |
| Normal-vs-Asian |
1.59980000002946E-06 |
| Caucasian-vs-AfricanAmerican |
1.912590E-01 |
| Caucasian-vs-Asian |
1.015390E-01 |
| AfricanAmerican-vs-Asian |
2.623000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.40370000032564E-07 |
| Normal-vs-Female |
7.02660041262959E-10 |
| Male-vs-Female |
5.792500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.029400E-01 |
| Normal-vs-Age(41-60Yrs) |
8.3545004248009E-10 |
| Normal-vs-Age(61-80Yrs) |
4.37519999996194E-06 |
| Normal-vs-Age(81-100Yrs) |
6.674200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.365170E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.710800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.568800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.736000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.968400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.169000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.400500E-03 |
| Normal-vs-Grade 2 |
6.77410350036212E-11 |
| Normal-vs-Grade 3 |
1.81133999999084E-05 |
| Normal-vs-Grade 4 |
3.104000E-01 |
| Grade 1-vs-Grade 2 |
9.759800E-02 |
| Grade 1-vs-Grade 3 |
5.962900E-03 |
| Grade 1-vs-Grade 4 |
8.026100E-04 |
| Grade 2-vs-Grade 3 |
1.487850E-02 |
| Grade 2-vs-Grade 4 |
3.167700E-04 |
| Grade 3-vs-Grade 4 |
3.436100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.922240144836E-12 |
| Normal-vs-ccB subtype |
1.279860E-02 |
| ccA subtype-vs-ccB subtype |
2.34759999995227E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.04420000424099E-08 |
| Normal-vs-N1 |
9.420200E-01 |
| N0-vs-N1 |
5.555900E-03 |
|
|
